Psoriasis Market Research Reports & Industry Analysis
Psoriasis Industry Research & Market Reports
-
The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Psoriasis Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Psoriasis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Psoriasis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Biologics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitors for Psoriasis Drugs
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Psoriatic Arthritis Treatment Global Market Report 2024
... Retail Pharmacies; Online PharmaciesCovering: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation Psoriatic Arthritis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 - 2032
... Devices Market will grow at an 8.3% CAGR from 2024 to 2032, fueled by the growing prevalence of actinic keratosis coupled with rapid technological advancements. Actinic keratosis cases are on the rise due to factors ... Read More
-
Digital Marketing Trends in Psoriasis - January 2024
... This was followed by Amgen’s Otezla.com (1.7 million visits). Overall, the highest proportion of traffic to top branded patient PsO websites originated from organic sources, followed by direct searches. Skyrizi.com had the highest level of ... Read More
-
Skincare Devices Market by Product (Diagnostic Devices, Treatment Devices), Application (Acne, Psoriasis, and Tattoo Removal, Body Contouring and Fat Removal, Cellulite Reduction), End-Use - Global Forecast 2024-2030
... USD 13.93 billion in 2023 and expected to reach USD 15.02 billion in 2024, at a CAGR 9.81% to reach USD 26.83 billion by 2030. Global Skincare Devices Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Tofacitinib Global Market Opportunities And Strategies To 2032 Including: 1) By Drug Class: Antirheumatic; Janus kinase inhibitor; Immunosuppressant 2) By Dosage Strength: 5mg; 10mg; 11mg; 22mg 3) By Indication: Ulcerative Colitis; Rheumatoid Arthritis; Psoriasis 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited
... Pharmacy; Retail Pharmacy; Online PharmacyCovering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited Tofacitinib Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; ... Read More
-
Generalized Pustular Psoriasis (GPP) - Competitive Landscape
... 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for GPP. The majority of marketed drugs indicated to treat GPP are monoclonal antibodies. Out of eight molecules in the pipeline for GPP, the late-stage ... Read More
-
Psoriatic Arthritis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 15.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.57% during 2022-2028. Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary ... Read More
-
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report provides top line data relating to the clinical trials ... Read More
-
Global Plaque Psoriasis Treatment Market - 2023-2030
... the forecast period 2023-2030. Plaque psoriasis also known as psoriasis vulgaris is a long-lasting and chronic autoimmune skin disease that causes cells to reproduce very quickly. It’s the most common type of psoriasis that causes ... Read More
-
Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, and Other Drug Classes), and By Region, Competition
... with an expected Compound Annual Growth Rate (CAGR) of 7.98% through 2028. This market is undergoing significant expansion and innovation, fundamentally reshaping the landscape of healthcare technology. Disposable medical sensors have emerged as critical components ... Read More
-
Remicade Biosimilar Global Market Report 2023 Including: 1) By Type: 100mg/10ml; 500mg/50ml 2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis 3) By Application: Blood Disorders; Oncology Diseases Covering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
... Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd. Remicade Biosimilar Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
... worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions. The approval of the first antisense oligonucleotide drug, ... Read More
-
Chronic Plaque Psoriasis Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Alopecia; Global Summary 2023
... of per capita consumption, the market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6 million prevalent cases of PsA in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. There are 14 leading marketed drugs for the treatment of PsA, Janssen is the key player in the ... Read More
-
Global Immunology Market Size study & Forecast, by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others) by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
... Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029 Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% ... Read More
-
Global Plaque Psoriasis Treatment Market Report and Forecast 2023-2031
... of plaque psoriasis worldwide, coupled with the growing investment in research and development activities, is driving the growth of the market. The global plaque psoriasis treatment market is likely to grow at a CAGR of ... Read More
Research Assistance
